BioPharma Dive 15 déc. 2025 Kyverna to seek first clearance of a CAR-T therapy for autoimmune disease
BioPharma Dive 15 déc. 2025 How rare-disease teams can fine-tune COAs to bridge meaningful change and measurable progress
BioPharma Dive 11 déc. 2025 Biotech venture firm Apple Tree goes bankrupt amid dispute with billionaire backer